“Dermatologic immune-related adverse events with immune checkpoint inhibitors” (2022) Canadian Dermatology Today, 3(3), pp. 40–46. Available at: https://canadiandermatologytoday.com/article/view/3-3-jfri (Accessed: 19 March 2026).